CLOV News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

CL

Mkt Cap

$2.38B

Volume

3.29M

Next Earnings

November 3rd

Loading chart

CL

CLOVClover Health Investments, Corp

CLOV

Pay with—

Available Balance0.00

CL

Mkt Cap

$2.49B

Volume

3.29M

Next Earnings

November 3rd

Chart Financials Earnings News About Insider Filings

Global Insurtech Market Size, Share, Trends, and Forecast to 2035 | AI, Cloud, and Automation Drive 41.45% CAGR, Creating a USD 638 Billion OpportunityThe global insurtech market is expected to expand from USD 14 billion in 2026 to USD 638 billion by 2035, driven by adoption of AI, cloud computing, blockchain, machine learning, and IoT. Health insurtech leads market share, while North America dominates regionally with Asia expected to achieve higher growth rates. Strategic partnerships between traditional insurers and startups are fueling innovation and scalability.GlobeNewswire Inc. · Oct 9, 2026

Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027Clover Health announced that CMS awarded its PPO Medicare Advantage plans a 5-Star rating and HMO plans a 4.5-Star rating for 2027. The company grew Medicare Advantage membership ~48% year-over-year to over 157,000 members. Clover maintained its #1 ranking among non-SNP PPO plans with a HEDIS score of 4.82 out of 5 Stars for the third consecutive year, demonstrating the effectiveness of its Counterpart Assistant platform in supporting physician decision-making.GlobeNewswire Inc. · Oct 8, 2026

UPDATE – Clover Health Welcomes Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller M.D. to Its Board of DirectorsClover Health announced the appointments of former U.S. Senator Robert Torricelli and Dr. Brian J. Miller, M.D. to its Board of Directors, effective immediately. Senator Torricelli will serve on the Audit Committee while Dr. Miller will serve on the Clinical Committee. The appointments fill two board vacancies and bring the board to nine directors. Both appointees bring extensive experience in healthcare policy, Medicare Advantage, clinical practice, and business strategy.GlobeNewswire Inc. · Sep 24, 2026

Clover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D. to Its Board of DirectorsClover Health announced the appointments of former U.S. Senator Robert Torricelli and Dr. Brian J. Miller, M.D., to its Board of Directors, effective immediately. Torricelli will serve on the Audit Committee while Dr. Miller will serve on the Clinical Committee. Both appointments bring complementary expertise in healthcare policy, Medicare Advantage, clinical practice, and business strategy to strengthen the company's governance and execution.GlobeNewswire Inc. · Sep 24, 2026

Clover Health's CEO Just Sold 62,711 Shares for Tax Withholding. The Bigger News Comes Next Week.Clover Health CEO Andrew Toy sold 62,711 shares worth ~$292,860 on July 15, 2026, to cover tax withholding obligations from RSU vesting. The sale is non-discretionary and doesn't reflect a change in conviction. Toy retains a $44.68 million stake (~2% ownership). The stock has gained 57% over the past year but dropped 20% in July following a data breach disclosure. Q2 earnings are expected in early August.The Motley Fool · Jul 31, 2026

Clover Health's CEO Sold Company Shares Worth $1.7 Million. Here's What That Means for Investors.Clover Health CEO Andrew Toy sold 313,476 shares worth $1.67 million on July 1, 2026, representing a 3.16% reduction in his direct holdings. The sale was a non-discretionary tax withholding event tied to RSU vesting, not a signal of lost confidence. Toy retains 9.6 million shares, maintaining significant alignment with shareholders. The sale comes amid strong company performance, including a court-mandated Medicare rating upgrade and 51% year-over-year membership growth in Q1 2026.The Motley Fool · Jul 7, 2026

A Clover Health Director Sold Over 67,000 Company Shares. Here's a Closer Look at the Transaction.Clover Health board member Dr. Carladenise Armbrister Edwards sold 67,160 shares (~$230,000) on May 18, 2026, reducing her direct holdings by 19%. The sale occurred during muted stock performance, but the director has not sold additional shares despite the stock subsequently reaching a 52-week high of $5.49 following a favorable court ruling and strong Q1 earnings with 62% revenue growth.The Motley Fool · Jun 27, 2026

A Clover Health Insider Sold Over 220,000 Company Shares. What Does That Mean for Investors?Conrad Wai, CEO of Clover Health's Counterpart Health subsidiary, sold 220,426 shares for approximately $879,000 on May 28, 2026. The sale was part of a pre-arranged Rule 10b5-1 trading plan and should not concern investors, as Wai retains over 2.5 million shares. The transaction occurred during a strong period for the company, with Q1 2026 showing 62% revenue growth and 51% Medicare Advantage membership growth.The Motley Fool · Jun 5, 2026

MedTech's Edge: How AI and Remote Diagnostics Drive Scalable ValueThe healthcare sector is shifting toward outpatient clinics and ambulatory services, with AI-powered diagnostics and remote care technologies gaining significant traction. Multiple medtech companies are advancing innovative solutions: VentriPoint Diagnostics is expanding cardiac imaging to remote communities via partnership with First Light Health; Senseonics demonstrated strong real-world data for its year-long continuous glucose monitor; Microbot Medical achieved clinical milestones with its robotic endovascular system; LivaNova received FDA approval for its sleep apnea treatment device; and Clover Health showed AI-assisted primary care reduces hospitalizations in high-risk patients.Benzinga · Mar 27, 2026

$638 Bn Insurtech Market, 2035 - Collaborations Between Traditional Insurers and Insurtech Startups are Fueling Innovations and ExpansionThe global insurtech market is projected to grow from $14 billion in 2026 to $638 billion by 2035, at a CAGR of 41.45%. Growth is driven by AI, blockchain, cloud computing, and machine learning technologies, with collaborations between traditional insurers and startups accelerating innovation. North America leads the market, while Asia is expected to grow faster. Health insurance, managed services, and cloud computing segments dominate, with healthcare sector showing highest future growth potential.GlobeNewswire Inc. · Feb 16, 2026

to start trading

CL

CLOVClover Health Investments, Corp

CLOV

Pay with—

Available Balance0.00

Your PositionYou don't own any CLOV yet.

Related Tickers

Earnings